Press Releases

April 4, 2013

Seahorse Bioscience Announces AACR Travel Award Recipients

Seahorse Bioscience announces travel award recipients who will present data generated using XF technology at the American Association of Cancer Research (AACR) Annual Meeting, in Washington, DC, April 6-10, 2013.
Read More
April 1, 2013

Seahorse Bioscience Launches First Product from the Partnership with Baystate Medical Center and UMass Amherst

Seahorse Bioscience recently launched the XF Plasma Membrane Permeabilizer (PMP), a reagent that enables scientists to measure the biochemistry and mechanisms of mitochondrial dysfunction, without the need for mitochondrial isolation or detergent-based permeabilization methods.
Read More
February 22, 2013

Seahorse Bioscience XF Technology Yields Insights on Leukemia Stem Cell Metabolism and Potential New Leukemia Therapies

Seahorse Bioscience announced a new milestone: the 500th journal reference including XF assay data. The paper, titled BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells, will be published in the March 7, 2013 issue of the journal Cell Stem Cell.
Read More
December 7, 2012

Seahorse Bioscience Announces Asia Mito 2012 Travel Award Winners

Seahorse Bioscience, the world leader in instrumentation and assay kits for measuring cell metabolism announce the travel award recipients who presented at the Asia Mito 2012 Conference, in Beijing, November 2-5, 2012.
Read More
October 13, 2012

Seahorse Introduces XF^e - the World's Most Advanced Cell Metabolism Analyzer

Industry Gold Standard Makes Metabolic Measurements Easier
Read More
October 12, 2012

Seahorse Bioscience Announces Neuroscience 2012 Travel Award Winners

XF Technology Brings a New Perspective to Neuroscience Research
Read More
October 10, 2012

Seahorse Bioscience Achieves Major Milestone in Instrument Shipments

Over 557 XF Analyzers Shipped to 31 Countries
Read More
August 21, 2012

Seahorse Bioscience Listed on the Inc. 500|5000 List of Fastest-Growing Private Companies in America for 2012 with Three-Year Sales Growth of 183%

Seahorse Bioscience has been listed in the top 25% of the 2012 Inc. 500|5000 list of the fastest-growing, private companies in America, two years in a row.
Read More
August 15, 2012

PVLSI Announces Licensing Agreement of Intellectual Property to Seahorse Bioscience, Inc.

Seahorse Biosciences has licensed a patent, entitled "Methods, Compositions and Kits for Assaying Mitochondrial Function", developed in the laboratory of Dr. Nagendra Yadava, the John Adams Investigator at the Pioneer Valley Life Sciences Institute (PVLSI) and Dr. Alejandro Heuck, PhD, an assistant professor of biochemistry and molecular biology at the University of Massachusetts Amherst.
Read More
June 25, 2012

Seahorse Launches Reagent to Make Functional Fatty Acid Oxidation (FAO) Assays Easy

Seahorse Bioscience has announced the launch of its newest product, the XF Palmitate-BSA FAO Reagent, eliminating the need for radioactivity in fatty acid oxidation (FAO) assays.
Read More
May 14, 2012

Seahorse Bioscience Awarded Multi-Million € Marie Curie Grant for Mitochondrial European Educational Training (MEET) Program

A multi-million € Marie Curie grant has been awarded to an international consortium including 8 world-leading basic science and clinical centres of excellence, industry leaders Seahorse Bioscience and Khondrion, and a non-profit foundation.
Read More
April 19, 2012

Seahorse Announces the XF Glycolysis Stress Test Kit

Seahorse Bioscience announced the launch of its newest stress test kit at the American Association of Cancer Research (AACR) Annual Meeting 2012. The XF Glycolysis Stress Test Kit is the first Standard for measuring glycolytic capacity in cells.
Read More
March 15, 2012

Seahorse Bioscience’s Labware Division Achieves ISO 9001:2008 Certification

Seahorse Bioscience has announced that its Labware Division has achieved ISO 9001:2008 certification. ISO 9001:2008 is the latest ISO standard designation, and demonstrates Seahorse’s ongoing commitment to quality-of-service standards established by the International Organization for Standardization (ISO).
Read More
January 2, 2012

Seahorse Bioscience Announces 2012 XF Users’ Meeting in Asia

Seahorse Bioscience has announced that its 2012 XF Users’ Meeting, to be held February 28th – March 1st, 2012 will be held in Tokyo, Japan, and co-hosted by Seahorse’s Japan distributor, Primetech.
Read More
August 23, 2011

Seahorse Bioscience Named to the 2011 Inc. 500|5000 List of Fastest-Growing Private Companies in America

Seahorse Bioscience has been listed in the top 25% of the 2011 Inc. 500|5000 list of the fastest-growing, private companies in America, and is ranked 34th among the top 50 businesses in Massachusetts.
Read More
August 15, 2011

Seahorse Bioscience, Inc. Appoints Research Instruments Pte Ltd as Distributor in S.E. Asia

"Research Instruments Pte Ltd, with a great reputation in S. E. Asia, meets our requirements, allowing us to accelerate our sales in Singapore, Malaysia, and Thailand, as they have existing relationships with our ideal customer base." stated Steve Chomicz, VP Sales and Marketing for Seahorse.
Read More
March 2, 2011

Seahorse Bioscience, Inc. Appoints In Vitro Technologies Pty Ltd as new Distributor in Australia and New Zealand

Seahorse Bioscience, the leader in the design and development of instruments for assessing cellular bioenergetics, has announced In Vitro Technologies as the new distributor of Seahorse XF Analyzers and consumables in Australia and New Zealand.
Read More
September 20, 2010

Seahorse Bioscience to Present at 2010 UBS Global Life Sciences Conference

We believe that we are at the right place at the right time to ride a wave of interest in cell bioenergetics as it applies to Cancer, Obesity, Diabetes, Aging and Cardiovascular function.
Read More
July 17, 2010

Seahorse Bioscience to speak about Cellular Bioenergetics technology at 16th European Bioenergetics Conference [EBEC2010] in Warsaw

Breakthrough instrument changing bioenergetics research.
Read More
June 16, 2010

Symposium at the NIH Emphasizes Importance of Mitochondria in Cancer

Seahorse Bioscience Organizes Cancer and Mitochondrial Function Symposium at Natcher Conference Center.
Read More
February 22, 2010

Seahorse Bioscience, Inc. Secures $5 mil Growth Financing to Expand Worldwide Sales & Manufacturing Capacity

Seahorse Technology enhances drug discovery efforts in Cancer and Aging.
Read More
December 29, 2009

TheScientist Awards Seahorse XF96 Analyzer a Top Ten Innovation for 2009

XF Extracellular Flux Analyzer among the ten most exciting tools to impact the life sciences this year.
Read More
December 17, 2009

Seahorse Bioscience, Inc. Appoints Cell-Bio Biotechnology Co. Ltd Distributor in Taiwan

Asian Society for Mitochondrial Research Conference Highlights Taiwanese Researchers' Interest in Cellular Bioenergetics.
Read More
October 13, 2009

Seahorse Bioscience, Inc. Responds to Requests from Scientists in France, Appoints Proteigene Distributor

French Distributor to Enhance France's Access to Novel Technology.
Read More
September 9, 2009

Seahorse Bioscience to Present Novel Cellular Bioenergetics Data in Collaboration with University of Nebraska at AACR Metabolism and Cancer Conference

New instrument reveals the impact of genetic and nutrient factors in the malignant transformation of cancer cells.
Read More
May 29, 2009

New Cellular Bioenergetics Workshops Series Inaugurated by Seahorse Bioscience with Two of the World's Leading Bioenergetics Researchers.

David Nicholls and Martin Brand collaborate with Seahorse Bioscience, Inc. to organize an advanced XF mitochondrial workshop and will share their years of experience studying promising disease pathways with workshop attendees.
Read More
March 12, 2009

Seahorse XF96 Extracellular Flux Analyzer wins Best New Product Award for DRUG DISCOVERY at 2009 Molecular Medicine Conference

First analytical instrument for the kinetic measure of mitochondrial oxygen consumption and cytoplasmic glycolysis in a 96-well microplate.
Read More
March 9, 2009

Seahorse Bioscience, Inc. acquires BioProcessors Corp.

Market Vision, Engineering Know-how, and Smart Plastics Expertise Combine to bring Practical Cell Technologies to the Life Sciences.
Read More
January 6, 2009

New! Seahorse now offering Travel Awards to Graduate Students and Post-docs...

To support the exploration of cellular bioenergetics, Seahorse Bioscience offers travel awards to Graduate Students and Post Doctoral researchers who present a talk or poster citing data generated on the XF platform at scientific meetings and conferences.
Read More
October 7, 2008

Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics

Novel technology opens the door to the understanding of and possible treatments for obesity, diabetes, aging and cancer.
Read More
July 18, 2008

Seahorse Bioscience Receives Poster Award from The European Association for the Study of Obesity

Mechanism of Action of Metformin on Insulin Sensitization Poster Wins One of Three Prizes.
Read More
May 22, 2008

Seahorse Bioscience Enters into Agreement with Primetech Corporation to Bring XF Technology to Japanese Market

Japanese Distributor to Expand Global Reach of Novel Technology
Read More
January 17, 2008

Life Science Technologies Nano to Next Gen: Automation Gets Personal

Seahorse Bioscience is automating an up-and-coming area of bioscience research: mitochondrial activity.
Read More
August 10, 2007

Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan To Board Of Directors

New Board Member Brings Life Sciences Tools Experience to the Leader in Cellular Bioenergetic Profiling
Read More